Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.69 - $9.05 $125,772 - $170,140
-18,800 Reduced 24.58%
57,700 $401,000
Q2 2024

Aug 14, 2024

BUY
$6.5 - $8.91 $25,350 - $34,749
3,900 Added 5.37%
76,500 $596,000
Q1 2024

May 15, 2024

SELL
$5.37 - $8.35 $642,252 - $998,660
-119,600 Reduced 62.23%
72,600 $515,000
Q4 2023

Feb 14, 2024

SELL
$4.44 - $6.7 $442,224 - $667,320
-99,600 Reduced 34.13%
192,200 $1.29 Million
Q3 2023

Nov 14, 2023

BUY
$5.23 - $9.24 $1.17 Million - $2.06 Million
223,000 Added 324.13%
291,800 $1.64 Million
Q2 2023

Aug 14, 2023

SELL
$4.36 - $6.2 $40,984 - $58,280
-9,400 Reduced 12.02%
68,800 $379,000
Q1 2023

May 15, 2023

SELL
$4.71 - $6.66 $110,214 - $155,844
-23,400 Reduced 23.03%
78,200 $488,000
Q4 2022

Feb 14, 2023

SELL
$4.06 - $5.71 $126,265 - $177,581
-31,100 Reduced 23.44%
101,600 $473,000
Q3 2022

Nov 14, 2022

SELL
$4.67 - $7.81 $7,472 - $12,496
-1,600 Reduced 1.19%
132,700 $620,000

Others Institutions Holding GDRX

About GoodRx Holdings, Inc.


  • Ticker GDRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 84,394,800
  • Market Cap $375M
  • Description
  • GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated pri...
More about GDRX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.